|
1
|
Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD
and Chen XG: Separation and determination of active components in
Radix Salviae miltiorrhizae and its medicinal preparations by
nonaqueous capillary electrophoresis. J Sep Sci. 27:569–575. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou L, Zuo Z and Chow MS: Danshen: An
overview of its chemistry, pharmacology, pharmacokinetics, and
clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiu TL and Su CC: Tanshinone IIA induces
apoptosis in human lung cancer A549 cells through the induction of
reactive oxygen species and decreasing the mitochondrial membrane
potential. Int J Mol Med. 25:231–236. 2010.PubMed/NCBI
|
|
4
|
Su CC and Lin YH: Tanshinone IIA inhibits
human breast cancer cells through increased Bax to Bcl-xL ratios.
Int J Mol Med. 22:357–361. 2008.PubMed/NCBI
|
|
5
|
Yan MY, Chien SY, Kuo SJ, Chen DR and Su
CC: Tanshinone IIA inhibits BT-20 human breast cancer cell
proliferation through increasing caspase 12, GADD153 and
phospho-p38 protein expression. Int J Mol Med. 29:855–863.
2012.PubMed/NCBI
|
|
6
|
Cheng CY and Su CC: Tanshinone IIA
inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and
GADD153 protein expression. Int J Mol Med. 26:379–385.
2010.PubMed/NCBI
|
|
7
|
Huang CY, Chiu TL, Kuo SJ, Chien SY, Chen
DR and Su CC: Tanshinone IIA inhibits the growth of pancreatic
cancer BxPC 3 cells by decreasing protein expression of TCTP, MCL 1
and Bcl-xL. Mol Med Rep. 7:1045–1049. 2013.PubMed/NCBI
|
|
8
|
Su CC, Chen GW, Kang JC and Chan MH:
Growth inhibition and apoptosis induction by tanshinone IIA in
human colon adenocarcinoma cells. Planta Med. 74:1357–1362. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su CC: Tanshinone IIA inhibits human
gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl 1
and Bcl-xL and increasing Bax and CHOP protein expression. Int J
Mol Med. 34:1661–1668. 2014.PubMed/NCBI
|
|
10
|
Su CC: Tanshinone IIA inhibits gastric
carcinoma AGS cells through increasing p-p38, p-JNK and p53 but
reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res.
34:7097–7110. 2014.PubMed/NCBI
|
|
11
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu CY, Wu MS, Chen YJ, Chen CJ, Chen HP,
Shun CT, Chen GH, Huang SP and Lin JT: Clinicopathological
significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J
Cancer. 43:799–808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elnemr A, Yonemura Y, Bandou E, Kinoshita
K, Kawamura T, Takahashi S, Tochiori S, Endou Y and Sasaki T:
Expression of collagenase-3 (matrix metalloproteinase-13) in human
gastric cancer. Gastric Cancer. 6:30–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu M, Cao FL, Li NY, Liu YQ, Li YP and Lv
CL: Tanshinone IIA reverses the malignant phenotype of SGC7901
gastric cancer cells. Asian Pac J Cancer Prev. 14:173–177. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rodriguez LG, Wu X and Guan JL:
Wound-healing assay. Methods Mol Biol. 294:23–29. 2005.
|
|
17
|
Shen W, Xi H, Wei B and Chen L: The
prognostic role of matrix metalloproteinase 2 in gastric cancer: A
systematic review with meta-analysis. J Cancer Res Clin Oncol.
40:1003–1009. 2014. View Article : Google Scholar
|
|
18
|
de la Peña S, Sampieri CL, Ochoa-Lara M,
León-Córdoba K and Remes-Troche JM: Expression of the matrix
metallo-proteases 2, 14, 24, and 25 and tissue inhibitor 3 as
potential molecular markers in advanced human gastric cancer. Dis
Markers. 2014:2859062014. View Article : Google Scholar
|
|
19
|
Wang HL, Zhou PY, Zhang Y and Liu P:
Relationships between abnormal MMP2 expression and prognosis in
gastric cancer: A meta-analysis of cohort studies. Cancer Biother
Radiopharm. 29:166–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang TF, Guo L and Wang Q: Meta-analysis
of associations between four polymorphisms in the matrix
metalloproteinases gene and gastric cancer risk. Asian Pac J Cancer
Prev. 15:1263–1267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang Q, Lan F, Wang X, Yu Y, Ouyang X,
Zheng F, Han J, Lin Y, Xie Y, Xie F, et al: IL-1β-induced
activation of p38 promotes metastasis in gastric adenocarcinoma via
upregulation of AP-1/c-fos, MMP2 and MMP9. Mol Cancer. 31:13–18.
2014.
|
|
22
|
Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H
and Wang Y: Chloroquine inhibits MGC803 gastric cancer cell
migration via the Toll-like receptor 9/nuclear factor kappa B
signaling pathway. Mol Med Rep. 11:1366–1371. 2015.
|
